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Abstract Leukotactin-1 (Lkn-1)/CCL15 is a recently cloned
CC-chemokine that binds to the CCR1 and CCR3. Although
Lkn-1 has been known to function as a chemoattractant for
neutrophils, monocytes and lymphocytes, its cellular mechanism
remains unclear. To understand the mechanism of Lkn-1-induced
chemotaxis signaling, we examined the chemotactic activities of
human osteogenic sarcoma cells expressing CCR1 in response to
Lkn-1 using inhibitors of signaling molecules. Inhibitors of Gi/Go
protein, phospholipase C (PLC) and protein kinase CN (PKCN)
inhibited the chemotactic activity of Lkn-1 indicating that Lkn-
1-induced chemotaxis signal is transduced through Gi/Go protein,
PLC and PKCN. The activities of PLC and PKCN were also
enhanced by Lkn-1 stimulation. Chemotactic activity of Lkn-1
was inhibited by the treatment of cycloheximide and actinomycin
D suggesting that newly synthesized proteins are needed for
chemotaxis. Nuclear factor-UB (NF-UB) inhibitor reduced
chemotactic activity of Lkn-1. DNA binding activity of NF-UB
was also enhanced by Lkn-1 stimulation. These results suggest
that Lkn-1 transduces the signal through Gi/Go protein,
PLC, PKCN, NF-UB and newly synthesized proteins for
chemotaxis. ß 2002 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Chemokines are a large family of structurally homologous
small proteins containing four to six conserved cysteines
linked by disul¢de bonds. Chemokines and their receptors
play important roles in leukocyte tra⁄cking under in£amma-
tory conditions and many other immune responses through
the regulation of cell migration and growth [1^3]. Two major
chemokine receptor groups, CCR and CXCR, belong to the
seven-transmembrane G protein-coupled receptor (GPCR)
superfamily. GPCRs transduce signals to the inside of the
cell through heterotrimeric G proteins which are grouped
into two families depending on the sensitivity to pertussis
toxin (PTX). Gi/Go family G proteins are sensitive to PTX
whereas Gq family G proteins are known to be insensitive to
this toxin [4]. Activation of the GPCR-mediated signaling
pathway involves the activation of several di¡erent e¡ector
molecules such as adenylate cyclase, phospholipase C (PLC),
PLD, PLA2, phosphoinositide-3 (PI-3) kinase, protein kinase
C (PKC) and Ca2 mobilization which initiate a variety of
cellular responses [5,6].
Recently, leukotactin-1 (Lkn-1)/CCL15, a member of the
CC chemokine family, has been cloned and partially charac-
terized [7,8]. Lkn-1 has been known to bind CCR1 and
CCR3, and has a chemoattractant role for neutrophils, mono-
cytes and lymphocytes [7]. Although Lkn-1 is believed to play
an important role in the development of in£ammation and
allergic in£ammatory diseases, its biological function and
the mechanism of cell migration events remain to be charac-
terized. CCR1 is a GPCR that is expressed by a variety of
cells, including lymphocytes, monocytes, basophils, eosino-
phils, and neutrophils [9]. CCR1-mediated signal transduction
pathways have been proposed. For example, it has been re-
ported that myeloid progenitor inhibitor factor-1 signal trans-
duction includes binding to CCR1, transduction by G protein,
e¡ector function by PLC, PKC, calcium £ux and PLA2, and
cytoskeletal remodeling [10]. Although CCR1 and Lkn-1 may
play important roles in physiologic processes, little informa-
tion is available regarding the Lkn-1-induced signal transduc-
tion pathway via CCR1 and the relationship of signaling
events to the functional response of the cell. In this study,
we investigated the mechanism of Lkn-1-induced chemotaxis
signal transduction via CCR1 using human osteogenic sarco-
ma cells expressing CCR1 (HOS/CCR1) as a model system.
2. Materials and methods
2.1. Materials
Dulbecco’s modi¢ed Eagle’s medium (DMEM), RPMI 1640, and
fetal bovine serum (FBS) were purchased from Life Technologies, Inc.
(Gaithersburg, MD, USA). PTX, PD98059, U73122, Ly294002, gen-
istein, rottlerin, Ro-31-8425, SB202190, SN50, cycloheximide (CHX),
and actinomycin D (ActD) were obtained from Calbiochem (San Die-
go, CA, USA). Quinacrine and rat tail collagen type I were products
of Sigma (St. Louis, MO, USA). rLkn-1 was the kind gift of Green-
cross Life Science Corp. (Yongin, Korea). hMIP-1K/CCL3, hMIP-1L/
CCL4, anti-CCR1 antibody and anti-CCR5 antibody were obtained
from RpD Systems (Minneapolis, MN, USA). Antibody against
PKCN was purchased from Transduction Laboratories (Lexington,
KY, USA). [Q-32P]ATP and myo-[2-3H]inositol were purchased from
Amersham Pharmacia Biotech. (Piscataway, NJ, USA). Stable HOS
cells expressing CCR1 or CCR5 were the kind gift of Dr. O.M. How-
ard (National Cancer Institute, MD, USA) and were grown in
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DMEM supplemented with 10% heat-inactivated FBS, penicillin (100
U/ml), streptomycin (100 Wg/ml), and puromycin (0.5 Wg/ml).
2.2. FACS analysis
HOS cells seeded into 100 mm dishes at 5U105 cells/dish were
cultured in DMEM. Cells were harvested and washed with phos-
phate-bu¡ered saline (PBS) bu¡er. After saturation of non-speci¢c
binding sites with total rabbit IgG, cells were incubated at 4‡C for
30 min with anti-CCR1 or anti-CCR5 antibodies. Baseline staining
was obtained by incubating mouse IgG instead of anti-CCR1 or anti-
CCR5 antibodies. Following incubation and washings, cells were in-
cubated at 4‡C for 30 min with FITC-conjugated goat anti-mouse
IgG. Finally, cells were washed and analyzed on a FACSort cyto-
£uorimeter (Becton Dickinson, San Jose, CA, USA).
2.3. Chemotaxis assay
Migration of cells was monitored using a 48-well microchamber
(Neuroprobe, Cabin John, MD, USA) as previously described [7].
Brie£y, the lower wells were ¢lled with 28 Wl bu¡er alone or with
bu¡er containing rLkn-1, hMIP-1K or hMIP-1L and the upper wells
were ¢lled with 50 Wl of HOS cells at 5U105 cells/ml in RPMI 1640
containing 1% bovine serum albumin (BSA) and 30 mM HEPES. The
two compartments were separated by a polyvinylpyrrolidone-free ¢lter
(Neuroprobe) with 10 Wm pores that was pre-coated with RPMI 1640
containing rat tail collagen type I at 4‡C overnight. After incubation
for 3 h at 37‡C, the ¢lters were removed from the chamber, washed,
¢xed, and stained with Di¡-Quick (Baxter, Deer¢eld, IL, USA). The
cells of two randomly selected oil-immersed ¢elds were counted using
Axiovert 25 (Carl Zeiss, Jena, Germany) and Visus Image Analysis
System (Foresthill Products, Foresthill, CA, USA). The chemotactic
index (CI) was calculated from the number of cells that migrated to
the control. Signi¢cant chemotaxis was de¢ned as CIs 2.
2.4. Measurement of PLC activity
HOS cells seeded into 35 mm dishes at 2U105 cells/dish were cul-
tured in DMEM. The cells were labeled with myo-[2-3H]inositol (2
mCi/ml) in inositol-free DMEM for 24 h. Subsequently, the labeled
cells were washed and pre-treated with 20 mM LiCl for 15 min in
DMEM containing 20 mM HEPES (pH 7.2) and 1 mg/ml BSA. Stim-
ulation was initiated by the addition of Lkn-1 for di¡erent times, and
terminated by the addition of ice-cold 5% HClO4. After 30 min in an
ice bath, extracts were centrifuged and diluted with distilled water,
and applied to Dowex AG 1-X8 anion exchange column (Bio-Rad,
Hercules, CA, USA). The column was then washed with 10 ml of
distilled water followed by 10 ml of 0.06 M ammonium formate con-
taining 5 mM sodium tetraborate. Total inositol phosphates were
eluted with a solution containing 1 M ammonium formate and 0.1
M formic acid.
2.5. PKC translocation assay
HOS cells seeded into 100 mm dishes at 5U105 cells/dish were
cultured in DMEM. The cells were starved for 24 h in 0.5% FBS.
After treatment with Lkn-1, the cells were harvested and washed three
times with ice-cold PBS (without Ca2). The cells then were resus-
pended in 200 Wl of homogenization bu¡er A (50 mM Tris^HCl, pH
7.4, 25 mM KCl, 5 mM MgCl2, 1 mM EGTA, 1 mM PMSF, and
protease inhibitors) and homogenized at 4‡C by 10 passages through a
21G needle ¢tted on a 1 ml plastic syringe. The homogenate was
centrifuged at 1000Ug for 5 min at 4‡C. The supernatant was col-
lected and centrifuged at 100 000Ug for 1 h at 4‡C. The supernatant
was collected as a cytosolic fraction. The pellet was resuspended in
100 Wl of homogenization bu¡er B (50 mM Tris^HCl, pH 7.4, 150
mM NaCl, 0.5% sodium deoxycholate, 1% NP-40, 0.1% SDS, 10 mM
EGTA, 1 mM PMSF, and protease inhibitors) and sonicated for 10 s.
The suspension was centrifuged at 100 000Ug for 30 min at 4‡C. The
supernatant was collected as a membrane fraction. Protein concentra-
tion of each sample was determined.
2.6. Western Blot analysis
Cells were lysed in 10 mM HEPES, 10 mM NaCl, 0.1 mM EDTA,
0.1 mM EGTA, 1% NP-40, 0.5 mM PMSF, 0.1 mM DTT, 0.1 mM
Na3VO4, and protease inhibitors. Protein samples (15 Wg of each)
were separated by SDS^PAGE (10%) and transferred to nitrocellulose
¢lters. The blots were incubated with antibodies and developed with
the enhanced chemiluminescence detection system (Amersham Phar-
macia Biotech.).
2.7. Electrophoretic mobility shift assay (EMSA)
For the nuclear factor-UB (NF-UB) gel shift assay, nuclear extracts
were prepared as described [11] from HOS/CCR1 cells. A double-
Fig. 1. Lkn-1 induces cell migration in HOS cells expressing CCR1. HOS/CCR1 cells (A) or HOS/CCR5 cells (B) were harvested and analyzed
by £uorescence-activated cells sorter using monoclonal anti-CCR1, anti-CCR5 antibodies (thick line) or control mouse IgG (thin line). HOS/
CCR1 cells (C) or HOS/CCR5 cells (D) were applied to the indicated concentrations of Lkn-1 (F), MIP1-K (8) or MIP1-L (b) in a micro-
chamber and were allowed to migrate for 3 h. The number of cells that migrated was counted microscopically in two randomly selected ¢elds
per well. The CI was calculated from the number of cells migrating to the test chemokines divided by that migrating to the controls. Results
are expressed as mean CI þ S.E.M. of six replicate measurements from a single experiment and it is representative of three separate experi-
ments.
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stranded oligonucleotide containing a consensus binding site for
NF-UB (underlined), 5P-AGTTGAGGGGACTTTCCCAGGC-3P,
was obtained from Promega (Madison, WI, USA). The oligonucleo-
tide was 5P-end-labeled with [Q-32P]ATP using T4 polynucleotide ki-
nase (Promega). Unincorporated nucleotide was removed by passage
over a Bio-Gel P-6 spin column (Bio-Rad) as described by manufac-
turer’s instruction. Nuclear extracts (15 Wg of total protein) were in-
cubated with radiolabeled probe for 20 min at room temperature, and
protein^DNA complexes were separated from free probe by electro-
phoresis on a 4% native polyacrylamide gel in 0.5U Tris^borate
EDTA (TBE). DNA binding bu¡er contained 10 mM Tris^HCl, pH
7.5, 1 mM MgCl2, 50 mM NaCl, 0.5 mM EDTA, 4% glycerol, 0.5
mM DTT, and 50 Wg/ml of poly(dI-dC)cpoly(dI-dC). Gels were pre-
electrophoresed in 0.5U TBE for 30 min prior to loading and elec-
trophoresis continued for approximately 3 h until the bromophenol
blue dye approached the bottom of the gel. Dried gels were visualized
by autoradiography. In competition experiments, binding reactions
were incubated with 10-fold molar excess of unlabeled NF-UB binding
oligonucleotide or NFAT binding oligonucleotide for 20 min before
addition of the radiolabeled oligonucleotide.
3. Results
3.1. Lkn-1 induces cell migration in HOS cells expressing
CCR1
A stable HOS cell line expressing CCR1 (HOS/CCR1) was
established to investigate Lkn-1-induced chemotaxis signaling
through CCR1 [7]. HOS/CCR5 was also established and used
as a negative control for Lkn-1 stimulation [7]. To examine
the surface expression of CCR1 and CCR5 on HOS cells,
FACS analysis was conducted. Fig. 1A,B shows that CCR1
and CCR5 are expressed on the surface of HOS cells. To
examine the chemotactic activity of Lkn-1 in HOS/CCR1
cells, cell migration assay was performed in a 48 well micro-
chamber. The chemoattractant e¡ect of Lkn-1 was compara-
ble to that of MIP-1K in HOS/CCR1, but MIP-1L did not
a¡ect migration of HOS/CCR1 (Fig. 1C). Lkn-1 showed the
typical bell-shape curve in HOS/CCR1 chemoattraction with
the peak of the curve at 100 ng/ml and MIP-1K showed the
maximum activity at 1 ng/ml. Lkn-1 did not show any chemo-
tactic activity in HOS/CCR5 cells whereas MIP-1K and MIP-
1L had chemoattractant e¡ects in HOS/CCR5 (Fig. 1D).
These data indicate that Lkn-1 shares receptor CCR1 with
MIP-1K but not with MIP-1L.
3.2. Lkn-1-induced chemotaxis is mediated via Gi/Go protein
and PLC
To evaluate the coupling mechanism of the Lkn-1 receptor
and the nature of possible G proteins involved in the signaling
events activated by Lkn-1, HOS/CCR1 was treated with PTX
before the stimulation of Lkn-1 or MIP-1K as a control. Fig.
2A shows that PTX has inhibitory e¡ects on the Lkn-1 and
MIP-1K-induced chemotaxis. In the presence of PTX, the
number of the cells a¡ected by Lkn-1 decreased to only 10^
20% of the number that migrated in the absence of PTX.
These data indicated that Lkn-1 exerts its e¡ect through a
receptor linked to a PTX-sensitive Gi/Go family G proteins.
To further characterize the chemotaxis signaling pathway
implicated in response to Lkn-1, we investigated the possible
involvement of PLC. Fig. 2B shows that Lkn-1 and MIP-1K-
induced cell migration are inhibited by the treatment of
U73122. This result indicates that PLC is involved in Lkn-1-
induced chemotaxis. We also determined the activity of PLC
in response to Lkn-1. Exposure of HOS/CCR1 to Lkn-1 for
di¡erent periods of time resulted in increased activities of PLC
as assessed by measuring the [3H]IP that was produced by
PLC activity (Fig. 2C). Increased activation was observed
within 5 min after addition of Lkn-1 to HOS/CCR1, and
continued to increase up to 1 h, but no PLC activation was
detected in HOS/CCR5.
3.3. PKCN is involved in Lkn-1-induced chemotaxis signaling
Since Gi/Go protein and PLC participated in Lkn-1-induced
chemotaxis, we examined whether possible downstream regu-
lator PKC is involved in the chemotaxis pathway of Lkn-1.
As shown in Fig. 3A, chemotactic activities of Lkn-1 and
MIP-1K were inhibited in the presence of rottlerin but not
in the presence of Ro-31-8425. Since rottlerin is a PKCN-spe-
ci¢c inhibitor, this result indicates that PKCN is involved in
Lkn-1-induced chemotaxis among various PKC isoforms.
Translocation of PKC to a particulate fraction is the key
step for the activation of this enzyme [12]. Determination of
Fig. 2. Lkn-1-induced chemotaxis is mediated via Gi/Go protein and
PLC. A: HOS/CCR1 cells were pre-incubated in the absence (con-
trol) or presence of 100 ng/ml PTX for 16 h. Cell migration in re-
sponse to Lkn-1 (100 ng/ml, black bars) or MIP-1K (1 ng/ml, white
bars) was measured as described in Section 2. B: HOS/CCR1 cells
were pre-incubated in the absence or presence of U73122 for 30
min at 0.5 and 1 WM. Cell migration in response to Lkn-1 (100 ng/
ml, black bars) or MIP-1K (1 ng/ml, white bars) was measured as
described in Section 2. C: HOS/CCR1 (F) or HOS/CCR5 (8) cells
were radiolabeled with myo-[2-3H]inositol (2 W Ci/ml) in inositol-
free DMEM for 24 h. Then, HOS cells were stimulated with 100
ng/ml Lkn-1 for the indicated times. Results are expressed as the ra-
dioactivity in the total inositol phosphates. Each point represents
the average value of three di¡erent experiments þ S.E.M.
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PKC content in membranes can re£ect PKC activity. To
investigate whether PKCN is activated by Lkn-1 stimulation,
we analyzed the membrane/cytosol distribution of PKCN.
PKCN activity began to increase at 10 min after addition of
Lkn-1 and the maximum activity of PKCN was detected at
60 min by the Western blot analysis (Fig. 3B). These results
indicate that Lkn-1 transduces the signal to PKCN for chemo-
taxis.
To determine other signaling molecules contributing to
Lkn-1-induced chemotaxis, we tested the respective e¡ects of
inhibitors of MEK (PD98059), p38 (SB202190), tyrosine ki-
nase (genistein), PI-3 kinase (Ly294002), PLA2 (quinacrine),
and PLD (1-butanol) on chemotactic activity of Lkn-1. Lkn-
1-induced cell migration was not inhibited by the addition of
these inhibitors suggesting that these molecules are not in-
volved in Lkn-1-induced chemotaxis (Fig. 3C).
3.4. Lkn-1 enhances NF-UB activation
Since many cellular processes need newly synthesized pro-
teins to carry out distinct functions, we tested the e¡ects of
ActD and CHX on Lkn-1-induced chemotaxis. As shown in
Fig. 4A, both inhibitors reduced the chemotactic activities of
Lkn-1 and MIP-1K to 20^30% of the control group indicating
that chemotaxis induced by Lkn-1 and MIP-1K needs newly
synthesized proteins. Inhibition of Lkn-1-induced chemotaxis
by transcription/translation inhibitors prompted us to test the
activation of transcription factors. Since NF-UB is activated
by several chemokines [13,14], we investigated whether Lkn-1
induces the activation of NF-UB in HOS/CCR1 cells. We per-
formed EMSA to evaluate the DNA binding activity of NF-
UB in HOS/CCR1 cells treated with Lkn-1 for the indicated
times by using a 32P-labeled consensus NF-UB DNA binding
sequence as a probe. Fig. 4B shows that there are two shifted
NF-UB nuclear complexes bound to the probe, and Lkn-1
induces an increase in the formation of these complexes
over time (0.5^4 h). Based on supershift EMSA, the lower
band consisted of the p50 homodimer, whereas the upper
band is the p65/p50 heterodimer (data not shown). To deter-
mine the speci¢city of NF-UB binding activity, nuclear ex-
tracts from the 2 h time point were incubated with the labeled
NF-UB binding probes in the absence or presence of a 10-fold
molar excess of unlabeled NF-UB or NFAT binding compet-
itor (Fig. 4B). The competition experiments showed that NF-
UB binding complex was competed with unlabeled NF-UB
binding probes, but not with NFAT binding probes indicating
that NF-UB binding activity is speci¢c. DNA binding ability
of NF-UB decreased in the presence of inhibitors of Gi/Go
protein, PLC and PKCN (Fig. 4C) demonstrating that these
molecules are the upstream regulators of NF-UB. Especially, a
PKCN-speci¢c inhibitor, rottlerin, completely blocked the
DNA binding of NF-UB at the concentration of 5 WM. How-
ever, Ro-31-8425 which does not inhibit PKCN had no inhib-
itory e¡ect on NF-UB activation. We also tested e¡ects of a
speci¢c inhibitor of NF-UB nuclear translocation on Lkn-1-
induced chemotaxis. Fig. 4D demonstrates that NF-UB inhib-
itor SN50 decreased the migrated cell number to 50% of the
control group at 36 WM. Taken together, our data suggest
that Lkn-1-induced chemotaxis requires new proteins to func-
tion, and the addition of Lkn-1 enhances NF-UB activity,
which is involved in the expression of many regulator pro-
teins.
4. Discussion
Despite substantial recent advances in our understanding of
chemotaxis, the precise mechanism through which cells re-
spond to a chemotactic gradient remains unclear. In this con-
tribution, we tried to understand the mechanism of Lkn-1-
induced chemotaxis signaling through CCR1 in HOS cells.
We have demonstrated that (1) Lkn-1 transduces the signal
via PTX-sensitive Gi/Go family G proteins; (2) Lkn-1 acti-
vates PLC and PKCN in a time-dependent manner; (3) Lkn-
1 enhances the DNA binding activity of NF-UB; cell migra-
tion assay showed that (4) Gi/Go protein, PLC, PKCN, NF-UB
and newly synthesized proteins are involved in Lkn-1-induced
chemotaxis, but ERK, p38, tyrosine kinases, PI-3 kinase,
PLA2, and PLD are not involved in the chemotaxis pathway
of Lkn-1.
Since expression levels of CCR1 in resting neutrophils, lym-
phocytes, and monocytes are relatively low, CCR1 overex-
pression HOS cell line was used to examine the Lkn-1-stimu-
lated signal transduction. The sensitivity to chemokines and
Fig. 3. PKCN is involved in Lkn-1-induced signaling. A: HOS/
CCR1 cells were pre-incubated in the absence or presence of rottler-
in (5, 10 and 20 WM) and Ro-31-8425 (50 nM) for 30 min. Cell mi-
gration in response to Lkn-1 (100 ng/ml, black bars) or MIP-1K (1
ng/ml, white bars) was measured as described in Section 2. B: Se-
rum-starved HOS/CCR1 cells were stimulated with 100 ng/ml Lkn-1
for the indicated times. Harvested cells were fractionated as de-
scribed in Section 2, then analyzed by 10% SDS^polyacrylamide
gels (15 Wg/lane) and transferred to nitrocellulose membrane. PKCN
translocation was detected by Western blotting with anti-PKCN anti-
body. C: HOS/CCR1 cells were pre-incubated in the absence (con-
trol) or presence of PD98059 (50 WM), SB202190 (20 WM), genistein
(10 WM), Ly294002 (10 WM), quinacrine (10 WM), and 1-butanol
(0.3%) for 30 min. Cell migration in response to Lkn-1 (100 ng/ml)
was measured as described in Section 2.
FEBS 25912 28-3-02
J. Ko et al./FEBS Letters 515 (2002) 159^164162
cell migration activity of HOS/CCR1 were comparable to that
of leukocytes from human PBMC ([7] and Fig. 1).
Accumulating data have implicated that multiple signaling
mechanisms exist to regulate cell migration. Mitogen-acti-
vated protein kinase [15,16], PI-3 kinase [13,17,18] and PKC
[19] signaling pathways have been shown to regulate the cell
migration induced by chemokines or cytokines. Most of these
signaling pathways are initiated with GPCR. A classical mod-
el for signal transduction by chemokines involves GPCR
whose a⁄nity state is increased by conformational changes
induced by association with the GDP-bound state of a
PTX-sensitive heterotrimeric G protein. Upon ligand binding,
the activated receptor catalyzes exchange of GDP for GTP by
the G protein K subunit, resulting in dissociation of K from LQ
subunits. In turn, LQ activates a phosphoinositide-speci¢c PLC
leading to the accumulation of IP3 and DAG in the cyto-
plasm. These products induce mobilization of calcium and
activation of PKC, respectively [20]. Besides the classical mod-
el, other pathways for GPCR that have been studied include
JAK/STAT, as well as both tyrosine and Ser/Thr kinases [3].
Our data from cell migration assay showed that Lkn-1-in-
duced chemotaxis was sensitive to PTX, indicating that Gi/
Go protein is involved in cell migration (Fig. 2A). In addition,
PLC and PKC participated in Lkn-1 signaling indicating that
Lkn-1 transduces the signal through the classical chemokine
signaling pathway (Figs. 2B and 3A). Among the various
PKC isoforms, PKCN was activated by Lkn-1 stimulation
and the PKCN speci¢c inhibitor rottlerin [21] blocked the che-
motactic activity of Lkn-1 (Fig. 3A). However, Ro-31-8425, a
PKC inhibitor that does not inhibit PKCN, showed no inhib-
itory activity of Lkn-1-induced chemotaxis. As any other nov-
el PKC, PKCN is activated in a Ca2-independent manner by
DAG, which is produced by activated PLC. To our knowl-
edge, this is the ¢rst report that PKCN is involved in chemo-
kine signaling.
The transcription factor NF-UB is critical for the expres-
sion of multiple genes involved in in£ammatory response
and apoptosis [22]. Proin£ammatory cytokines such as inter-
leukin-1 and tumor necrosis factor-K (TNF-K) rapidly acti-
vate NF-UB in most cell types through the NIK/MEKK-
IKK-IUB signal pathway [22,23]. These cytokines induce
NF-UB activation by modulating IUB phosphorylation, ubi-
quitination, and proteolytic degradation and by releasing
functional NF-UB dimers to translocate to the nucleus [24].
Chemotactic factors, such as the lipid mediator platelet-acti-
vating factor [25] and SDF-1 [13], are also reported to acti-
vate NF-UB in leukocytes or murine pre-B cells, respectively.
However, the mechanism of chemokine receptor activation
of NF-UB is not clear. Our studies suggest that Lkn-1 can
cause the activation of NF-UB. Lkn-1-induced cell migration
was reduced, but not completely inhibited by the NF-UB
inhibitor SN50, re£ecting the involvement of NF-UB in
Lkn-1-induced chemotaxis (Fig. 4D). Through Lkn-1-in-
duced activation of the NF-UB signaling pathway and pos-
sibly in conjunction with other signaling pathways, Lkn-1
probably promotes changes in cellular morphology, collec-
Fig. 4. Lkn-1 enhances the NF-UB activity. A: HOS/CCR1 cells were pre-incubated in the absence or presence of 10 Wg/ml ActD or 10 Wg/ml
CHX for 2 h. After the addition of Lkn-1 (100 ng/ml, black bars) or MIP-1K (1 ng/ml, white bars), migration assay was performed as de-
scribed in Section 2. B: Serum-starved HOS/CCR1 cells were treated with 100 ng/ml Lkn-1 for the indicated times. Nuclear extracts (15 Wg/
lane) were prepared and subjected to EMSA for DNA binding activity of NF-UB with 32P-end-labeled oligonucleotides in the absence or pres-
ence of 10-fold molar excess of unlabeled competitors. NF-UB, unlabeled NF-UB binding oligonucleotides; NFAT, unlabeled NFAT binding
oligonucleotides. Arrows indicate the shifts corresponding to the position of NF-UB protein^DNA complexes. C: Serum-starved HOS/CCR1
cells were pre-incubated in the absence or presence of PTX (100 ng/ml), U73122 (10 WM), rottlerin (5 WM) and Ro-31-8425 (50 nM) for 30 min
(16 h for PTX) and were treated with 100 ng/ml Lkn-1 for 2 h. Nuclear extracts (15 Wg/lane) were prepared and subjected to EMSA. D: HOS/
CCR1 cells were pre-incubated with SN50 (18 and 36 WM) for 30 min and migrated toward 100 ng/ml of Lkn-1 (black bars) or 1 ng/ml of
MIP-1K (white bars). Cell migration in response to Lkn-1 or MIP-1K was measured as described in Section 2.
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tively known as polarization, required for chemotactic re-
sponses.
It has been reported that NF-UB activation in TNF-K-
stimulated neutrophils is mediated by PKCN [26]. At present,
we do not know the downstream events regulated by PKCN
and leading to NF-UB activation and chemotaxis in Lkn-1-
stimulated HOS/CCR1 cells. One of the critical regulatory
steps dictating IUB degradation and NF-UB activation is
IUB kinase (IKK) and NF-UB inducing kinase (NIK) [27].
Recent studies demonstrated that IKKL is involved in NF-
UB activation through PKCa in T lymphocytes [28^30]. There-
fore, the possible roles of IKK isoforms or other cellular
molecules in Lkn-1-stimulated NF-UB activation are under
investigation.
In conclusion, the present study provides the characteriza-
tion of the chemotaxis signaling pathways activated by Lkn-1
in a model system of HOS/CCR1. We have demonstrated that
the binding of Lkn-1 to its Gi/Go protein coupled receptor
CCR1 leads to the speci¢c activation of PLC, PKCN, and NF-
UB, and that the PLC/PKCN/NF-UB pathway may mediate
Lkn-1-induced chemotactic activity. While further studies
are required to delineate the signaling pathways leading to
chemotaxis through CCR1 stimulation by Lkn-1, this is the
¢rst report characterizing the chemotaxis signaling events in
response to Lkn-1. Although we investigated Lkn-1-induced
chemotaxis signaling in the HOS/CCR1 model system, our
preliminary data using neutrophils showed the same results
and we are conducting the experiments using primary cells
naturally expressing CCR1. From this information, we can
begin to understand the molecular mechanism of cell migra-
tion and other cellular processes induced by Lkn-1 which are
important events in both physiological and pathological pro-
cesses.
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